Literature DB >> 9440052

Helicobacter pylori as a pathogen and carcinogen.

P Correa1.   

Abstract

Although recently recognized as a human pathogen. Helicobacter pylori has probably been present in humans for millenia. It represents the most common chronic infection in humans at the present time. Markedly different outcomes of the infection have been recognized, from asymptomatic mild gastritis to peptic ulcer and to lymphoid and epithelial gastric neoplasia. The factors determining the outcome are poorly understood and probably include bacterial, host and environmental forces. The mechanisms involved in carcinogenesis are probably multiple and include excessive cell replication, depletion of protective epithelial mucins and DNA damage related to misplaced release of oxidative species by leukocytes.

Entities:  

Mesh:

Year:  1997        PMID: 9440052

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  12 in total

Review 1.  Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

2.  Identification of common mechanisms between endometriosis and ovarian cancer.

Authors:  Qingsong Meng; Weixue Sun; John Jiang; Nicole M Fletcher; Michael P Diamond; Ghassan M Saed
Journal:  J Assist Reprod Genet       Date:  2011-05-26       Impact factor: 3.412

3.  Can eradication rate of gastric Helicobacter pylori be improved by killing oral Helicobacter pylori?

Authors:  Han-Yi Song; Yan Li
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

Review 4.  Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection.

Authors:  Francesco Franceschi; Robert M Genta; Antonio R Sepulveda
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

5.  Helicobacter pylori urease and flagellin alter mucin gene expression in human gastric cancer cells.

Authors:  Michaël Perrais; Christel Rousseaux; Marie-Paule Ducourouble; René Courcol; Pascal Vincent; Nicolas Jonckheere; Isabelle Van Seuningen
Journal:  Gastric Cancer       Date:  2013-05-24       Impact factor: 7.370

6.  Serologic Profile of Antiparietal Cell Antibodies, Pepsinogens, and H. pylori and Risk of Upper Gastrointestinal Cancer: A Nested Case-Control Study in China.

Authors:  Shao-Ming Wang; Mark J Roth; Gwen A Murphy; Sanford M Dawsey; Jin-Hu Fan; Philip R Taylor; You-Lin Qiao; Christian C Abnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-09       Impact factor: 4.254

7.  Malgun (clear) cell change in Helicobacter pylori gastritis reflects epithelial genomic damage and repair.

Authors:  Jaejung Jang; Seungkoo Lee; Yusun Jung; Kyuyoung Song; Manabu Fukumoto; Victor E Gould; Inchul Lee
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

8.  In Vitro Inhibition of Helicobacter pylori Growth by Redox Cycling Phenylaminojuglones.

Authors:  Julio Benites; Héctor Toledo; Felipe Salas; Angélica Guerrero; David Rios; Jaime A Valderrama; Pedro Buc Calderon
Journal:  Oxid Med Cell Longev       Date:  2018-04-24       Impact factor: 6.543

9.  Multiple infection and microdiversity among Helicobacter pylori isolates in a single host in India.

Authors:  Rajashree Patra; Santanu Chattopadhyay; Ronita De; Prachetash Ghosh; Mou Ganguly; Abhijit Chowdhury; T Ramamurthy; G B Nair; Asish K Mukhopadhyay
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

10.  Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.

Authors:  Musthafa Chalikandy Peedikayil; Fahad Ibrahim Alsohaibani; Abdullah Hamad Alkhenizan
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.